Latest ArticlesTo investigate the clinical features of latent autoimmune diabetes in adults (LADA) with albuminuria and relationship between albuminuria with atherosclerosis.
A total of 166 hospitalized patients with LADA were recruited in Shanghai Jiaotong university affiliated sixth people’s hospital from January 2007 to June 2009. According to the result of albuminuria, all subjects were divided into two groups, such as LADA without albuminuria group (n=142) and LADA with albuminuria group (n=24). The clinical data were collected and analyzed, including diabetes duration, smoking history, drinking history, medications, height, weight, waistline circumference, hip circumference, blood pressure, plasma glucose, blood lipids, C-peptide, renal function and liver function. The clinical features between two groups were compared and the relationship between albuminuria and atherosclerosis was also analyzed.
Compared with the LADA without albuminuria group, the age of patients in LADA with albuminuria group was older, after adjustment for age and sex, the patients had longer duration of diabetes, higher prevalence of hypertension, higher proportion of using antihypertensive drugs, and higher systolic blood pressure, creatinine, serum uric acid, 24 h of urinary albumin, triglyceride, and 2 h postprandial C-peptide (P < 0.05), and lower eGFR (P<0.05) in LADA with albuminuria group. In addition, the prevalence of atherosclerosis and atherosclerotic stenosis in LADA with albuminuria group were 91.7% and 20.8% respectively, which were higher than those in LADA without albuminuria group (66.2% and 7.0%, P<0.05). However, there was no significant difference in the intimal-medial thickness (IMT) of the carotid and femoral arteries between two groups (P>0.05). Binary logistic regression analysis showed that albuminuria was an independent risk factor for atherosclerosis in LADA patients (P<0.05).
The LADA patients with albuminuria have higher prevalence of atherosclerotic plaque and stenosis, which may be resulted from more serious metabolic disorder. Albuminuria is an independent risk factor associated with the presence of atherosclerosis in LADA patients.
To investigate the clinical effect and mechanism of Jianpi Bushen Huatan Fang in the treatment of stable chronic obstructive pulmonary disease (COPD) patients.
A total of 70 patients with stable COPD in our hospital were enrolled and 5 patients withdrew from the study. All the patients maintained the original regular medication program, they were divided into the Chinese medicine group (n=32, taken oral Jianpi Bushen Huatan Fang twice a day), and the control group (n=33, taken placebo twice a day). The treatment course was 2 months, and the follow-up was for 4 months. The traditional Chinese medicine (TCM) syndrome score was used to determine the TCM curative effect. The lung function was evaluated by the severity of the airflow limitation, and the COPD assessment test (CAT) was used for comprehensive evaluation. The peripheral blood immunocytic markers (CD4+ and CD8+ T lymphocyte), inflammatory cytokines and Th1/Th2 cytokine (TNF-α, IL-8, CXCL10, INF-γ and IL-4) were detected as well.
After 2 and 4 months follow-up, the total effective rate of Chinese medicine group was higher than that of the control group (P<0.05). After 4 months of follow-up, the mild patients with lung function grade and CAT score in Chinese medicine group were increased than those of control group, and the severe or the extremely severe patients with lung function grade and extremely severe patients with the CAT score in Chinese medicine group were reduced than those of control group (P<0.05). After 2 and 4 months of follow up, in Chinese medicine group the INF-γ, CXCL10 were decreased and the IL-4 was increased (P<0.05) compared with before treatment, and the INF-γ and CXCL10 were lower (P<0.05) compared with those in control group. After 2 and 4 months of follow-up, there was no significant difference in the TNF-α, IL-8, CD4+ and CD8+ T lymphocyte between the two groups (P>0.05).
Jianpi Bushen Huatan Fang can alleviate COPD disease progression and improve the life quality of stable COPD patients by regulating Th1/Th2 cytokine and improving CD4+ and CD8+ T lymphocytes.
To investigate the prognostic value of cystatin C (Cys C) in the degree of coronary artery disease in the patients with coronary heart disease complicated with cardiorenal syndrome type 1 (CRS 1).
The medical data of 102 hospitalized patients with CRS 1 from January 2014 to December 2016 in Shanghai general hospital Baoshan branch were reviewed. Based on the ratio of the minimum Cys C to the maximum Cys C value of the patients admitted to the hospital within 2 weeks, the 102 patients were divided into low, middle and high amplitude group with 34 cases in each group. The coronary angiography was performed during hospitalization, and the extent, severity and Gensini score of coronary artery lesions were observed in the three groups. The clinical predictive value of evaluating the amplitude of Cys C.
The baseline characteristics showed that the incidence of acute coronary syndrome in the high amplitude group was higher than that in the middle and low amplitude group (P<0.05). The glomerular filtration rate of high amplitude group was lower than that of the middle and low amplitude group (P<0.05). In the Gensini score, the score of high amplitude group was higher than that of middle and low amplitude group, and the score of middle amplitude group was higher than that of low amplitude group (P<0.05). The ratio of three lesions in the high amplitude group was higher than that in the middle and low amplitude group (P<0.05), and the incidence of single lesion and no lesion was lower than that of the middle and low amplitude group (P<0.05). The proportion of severe and moderate lesions in the high amplitude group was higher than that in the middle and low amplitude group (P<0.05), and the proportion of mild lesions was lower than that in the middle and low amplitude groups (P<0.05).
The fluctuation range of Cys C has certain predictive value for coronary artery disease in the patients with coronary heart disease complicated with CRS 1, the greater the fluctuation of Cys C, the wider the range of coronary lesions and the more serious the degree of coronary lesions.
To investigate the effect of benthiactzine in the treatment of organophosphorus poisoning with respiratory failure and its effects on cardiac function and oxidative stress products.
A total of 80 patients with organophosphorus poisoning accompanied by respiratory failure, who were treated in our hospital from April 2015 to March 2017, were selected and divided into control group and treatment group according to the treatment methods. The control group was treated with atropine, and the treatment group was treated with benthiactzine (2.0 mg/kg, intramuscular injection). The treatment success rate in two groups was observed, and the difference of cardiac function index [left ventricular ejection fraction (LVEF) and brain natriuretic peptide (BNP)], oxidative stress index [superoxide dismutase (SOD), malondialdehyde (MDA) and glutathione (GSH)], and liver and kidney function index [blood urea nitrogen (BUN), alanine aminotransferase (ALT), aspartate aminotransferase (AST)] in both two groups before and after treatment were compared.
The treatment success rate between the two groups had no significant difference (90.00% vs 77.50%, P>0.05). After treatment, the LVEF, SOD and GSH in treatment group were higher than those in control group, while the BNP, MDA, BUN, ALT and AST were lower than those in control group (P < 0.05).
Benthiactzine has a good effect on the patients with organophosphorus poisoning accompanied by respiratory failure, which can obviously improve patient's cardiac function and oxidative stress products level, and has certain protective effect on the liver and kidney function as well.
To investigate the effect of enalapril maleate and folic acid tablet on the carotid atherosclerosis in the hypertension patients with hyperhomocysteinemia (HHcy) and its related mechanism.
A total of 142 cases of patients with hypertension with HHcy were randomly divided into two groups: the control group (n=71) was received enalapril tablets (oral, once a day, 10 mg each time), the observation group (n=71) was received enalapril maleate and folic acid tablet (oral, once a day, 10 mg each time) for 6 months. The systolic pressure (SBP) and diastolic pressure (DBP) were measured before and after treatment. The plasma levels of Cystatin C (Cys C), OX40L and Hcy were detected by enzyme linked immunosorbent assay. Carotid intima media thickness (IMT) and Crouse scores were detected by color Doppler ultrasound of carotid artery. The brachial-ankle pulse wave velocity (baPWV) was detected by automatic arteriosclerosis determinator, and the changes of the above indexes before and after treatment were compared between the two groups. The incidence of major adverse cardiovascular events (MACE) was followed up.
The blood pressure compliance rate in observation group was higher than that in control group (60.56% vs 36.62%, P<0.05). After treatment, the SBP, DBP, Crouse score, IMT and baPWV and the plasma levels of Cys C, OX40L and Hcy in observation group were lower than those in control group (P<0.05). The incidence of MACE was 6.06% in observation group, which was significantly lower than that in control group (17.19%, P<0.05).
Enalapril maleate and folic acid tablet has exact effect for the hypertension patients with HHcy, which can inhibit the state of micro-inflammation, delay or even reverse the progression of carotid atherosclerosis, and reduce the risk of MACE. Its mechanism might be related to down-regulation of Cys C, OX40L and Hcy in peripheral blood.
The mammalian genomes contain nine genes of encoding protein arginine methyltransferase (PRMT), which can produce the protein catalyzing three types of arginine methylation modification. Protein arginine methylation serves as a diversified post-translational protein modification, as well as involves in signal transduction, gene transcription, DNA damage repair and mRNA splicing pathway. Recent studies have associated such biological changes to the malignancy development and metastasis. Overexpression of PRMT is often associated with various malignancies, which highlights them as potential ideal therapeutic targets for malignancy treatment. This review summarizes the classification and biological functions of PRMT, and its correlation with the occurrence and development of various malignancies including the research progress of PRMT inhibitors.
Cognitive impairment is the most frequent non-motor symptoms of Parkinson's disease (PD). Around 30% of the patients with PD experience mild cognitive impairment (MCI), which is a high risk factor for the development of dementia. The identification of biomarkers associated with dementia would allow the early diagnosis and intervention of individuals at high risk for dementia. This review summarizes the research progress on the potential biomarkers assessed dementia and MCI in PD patients.
Hepatocellular carcinoma (HCC) is one of the most common malignacies in the world. The incidence rate ranks sixth in the world for malignant tumors, and the mortality rate ranks second. Early diagnosis can increase the 5-year survival rate of HCC. However, the serological markers of HCC can effectively screen, diagnose the disease state, and monitor its treatment effect conveniently. It is economical, convenient and sensitive. This article reviews recent advances in HCC serological markers and provides a reference for HCC diagnosis and treatment.
Narcolepsy is a sleep-wake disorder and its four common clinical features are excessive daytime sleeps, cataplexy, hypnagogic and hypnopompic hallucinations, and sleep paralysis. This review summarizes diagnosis of narcolepsy encompasses clinical, electrophysiological and biological evaluations, and reviews current several symptomatic treatments of narcolepsy.